These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7152230)
1. Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia. Rastogi SK; Rastogi RB; Lapierre YD; Singhal RL Gen Pharmacol; 1982; 13(6):499-504. PubMed ID: 7152230 [No Abstract] [Full Text] [Related]
2. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats. Kääriäinen I Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):393-400. PubMed ID: 989685 [No Abstract] [Full Text] [Related]
8. Tardive dyskinesia: a role for the endogenous opioid system. Sandyk R Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480 [TBL] [Abstract][Full Text] [Related]
10. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775 [TBL] [Abstract][Full Text] [Related]
11. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine. Kelly PH; Moore KE Neuropharmacology; 1978 Mar; 17(3):169-74. PubMed ID: 643163 [No Abstract] [Full Text] [Related]
13. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats. Grimm JW; See RE Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113 [TBL] [Abstract][Full Text] [Related]
14. The nullification by diazepam of haloperidol-induced increases in the level of striatal dopamine but not in the activity of glutamic acid decarboxylase. Hama Y; Ebadi M Neuropharmacology; 1986 Nov; 25(11):1235-42. PubMed ID: 3796796 [TBL] [Abstract][Full Text] [Related]
15. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768 [TBL] [Abstract][Full Text] [Related]
16. Increase in mouse brain dopamine content by baclofen: effects of apomorphine and neuroleptics. Gianutsos G; Moore KE Psychopharmacology (Berl); 1977 May; 52(3):217-21. PubMed ID: 406622 [TBL] [Abstract][Full Text] [Related]
17. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain. Reches A; Jackson-Lewis V; Fahn S Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824 [TBL] [Abstract][Full Text] [Related]
18. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Gunne LM; Häggström JE; Sjöquist B Nature; 1984 May 24-30; 309(5966):347-9. PubMed ID: 6727989 [TBL] [Abstract][Full Text] [Related]
19. [Oral dyskinesia in rats after a single administration of haloperidol combined with GABA-linoleamide. A model of dyskinesia in man]. Vamvakides A Agressologie; 1989 Feb; 30(2):89-91. PubMed ID: 2735495 [TBL] [Abstract][Full Text] [Related]